Mon, 09 Dec 2019 16:59:24 GMT
France's Sanofi to acquire Synthorx in $2.5B deal
On Monday, France's Sanofi has agreed to acquire the California-based biotech firm Synthorx in the all-cash deal valued at $2.5B as the company paves its way into the lucrative cancer drugs field.